Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder

被引:4
|
作者
Lv, Hui [1 ,2 ]
Gu, Xiao [3 ]
Shan, Xingyue [4 ]
Zhu, Tailin [1 ,2 ]
Ma, Bingke [4 ]
Zhang, Hao-Tian [5 ,6 ]
Bambini-Junior, Victorio [7 ]
Zhang, Tiantian
Li, Wei-Guang [8 ,9 ]
Gao, Xiaoling [3 ]
Li, Fei [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Dev & Behav Pediat & Child Primary Care, Xinhua Hosp,Sch Med, Brain & Behav Res Unit,Shanghai Inst Pediat Res, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Minist Educ,Sch Med, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Univ Collaborat Innovat Ctr Translat Med, Sch Med, Dept Pharmacol & Chem Biol, Shanghai, Peoples R China
[4] East China Normal Univ, Minist Educ, Sch Life Sci, Shanghai Key Lab Brain Funct Genom, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Brain & Behav Res Unit,Shanghai Inst Pediat Res, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Minist Educ MOE,Sch Med, Shanghai, Peoples R China
[7] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England
[8] Fudan Univ, State Key Lab Med Neurobiol, Inst Translat Brain Res, Huashan Hosp,Dept Rehabil Med, Shanghai, Peoples R China
[9] Fudan Univ, Ctr Brain Sci, Minist Educ, Shanghai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
autism spectrum disorder; bumetanide; nanoparticle; social behavior; microglia; MICROGLIAL ACTIVATION; MOUSE MODEL; BRAIN; EXCITATION/INHIBITION; NANOPARTICLES; INHIBITION; DELIVERY; CORTEX; NKCC1;
D O I
10.3389/fimmu.2022.870577
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder with few medication options. Bumetanide, an FDA-approved diuretic, has been proposed as a viable candidate to treat core symptoms of ASD, however, neither the brain region related to its effect nor the cell-specific mechanism(s) is clear. The availability of nanoparticles provides a viable way to identify pharmacological mechanisms for use in ASD. Here, we found that treatment with bumetanide, in a systemic and medial prefrontal cortex (mPFC) region-specific way, attenuated social deficits in BTBR mice. Furthermore, using poly (ethylene glycol)-poly(l-lactide) (PEG-PLA) nanoparticles [NP(bumetanide)], we showed that the administration of NP(bumetanide) in a mPFC region-specific way also alleviated the social deficits of BTBR mice. Mechanistically, the behavioral effect of NP(bumetanide) was dependent on selective microglia-specific targeting in the mPFC. Pharmacological depletion of microglia significantly reduced the effect of nanoencapsulation and depletion of microglia alone did not improve the social deficits in BTBR mice. These findings suggest the potential therapeutic capabilities of nanotechnology for ASD, as well as the relevant link between bumetanide and immune cells.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Usefulness of the autism spectrum quotient (AQ) in screening for autism spectrum disorder and social communication disorder
    Yoshinaga, Kiyohiro
    Egawa, Jun
    Watanabe, Yuichiro
    Kasahara, Hiroyuki
    Sugimoto, Atsunori
    Someya, Toshiyuki
    BMC PSYCHIATRY, 2023, 23 (01)
  • [32] Usefulness of the autism spectrum quotient (AQ) in screening for autism spectrum disorder and social communication disorder
    Kiyohiro Yoshinaga
    Jun Egawa
    Yuichiro Watanabe
    Hiroyuki Kasahara
    Atsunori Sugimoto
    Toshiyuki Someya
    BMC Psychiatry, 23
  • [33] Circuits for social learning: A unified model and application to Autism Spectrum Disorder
    DeMayo, Marilena M.
    Young, Larry J.
    Hickie, Ian B.
    Song, Yun Ju C.
    Guastella, Adam J.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2019, 107 : 388 - 398
  • [34] Cathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism
    Wang, Huan
    Yin, Yi-Xuan
    Gong, Dong-Mei
    Hong, Ling-Juan
    Wu, Gang
    Jiang, Quan
    Wang, Cheng-Kun
    Blinder, Pablo
    Long, Sen
    Han, Feng
    Lu, Ying-Mei
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (04) : 476 - 485
  • [35] Creatine Transporter Deficiency Presenting as Autism Spectrum Disorder
    Yildiz, Yilmaz
    Gocmen, Rahsan
    Yaramis, Ahmet
    Coskun, Turgay
    Haliloglu, Goknur
    PEDIATRICS, 2020, 146 (05)
  • [36] SCGN deficiency is a risk factor for autism spectrum disorder
    Zhe Liu
    Shuai Tan
    Lianyu Zhou
    Li Chen
    Mingfeng Liu
    Wang Wang
    Yingying Tang
    Qin Yang
    Sensen Chi
    Peiyan Jiang
    Yue Zhang
    Yonghua Cui
    Junhong Qin
    Xiao Hu
    Shenglong Li
    Qi Liu
    Lu Chen
    Song Li
    Ezra Burstein
    Wei Li
    Xiaohu Zhang
    Xianming Mo
    Da Jia
    Signal Transduction and Targeted Therapy, 8
  • [37] SCGN deficiency is a risk factor for autism spectrum disorder
    Liu, Zhe
    Tan, Shuai
    Zhou, Lianyu
    Chen, Li
    Liu, Mingfeng
    Wang, Wang
    Tang, Yingying
    Yang, Qin
    Chi, Sensen
    Jiang, Peiyan
    Zhang, Yue
    Cui, Yonghua
    Qin, Junhong
    Hu, Xiao
    Li, Shenglong
    Liu, Qi
    Chen, Lu
    Li, Song
    Burstein, Ezra
    Li, Wei
    Zhang, Xiaohu
    Mo, Xianming
    Jia, Da
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [38] A Case with Autism Spectrum Disorder and Concomitant Arginase Deficiency
    Eren, Rabia
    Ozaydin, Buket Canlan
    Goksoy, Emine
    Yigit, Zehra Manav
    Ozgur, Borte Gurbuz
    JOURNAL OF BEHCET UZ CHILDRENS HOSPITAL, 2024, 14 (03): : 195 - 198
  • [39] Gestational vitamin D deficiency and autism spectrum disorder
    Vinkhuyzen, Anna A. E.
    Eyles, Darryl W.
    Burne, Thomas H. J.
    Blanken, Laura M. E.
    Kruithof, Claudia J.
    Verhulst, Frank
    White, Tonya
    Jaddoe, Vincent W.
    Tiemeier, Henning
    McGrath, John J.
    BJPSYCH OPEN, 2017, 3 (02): : 85 - 90
  • [40] A PheWAS Model of Autism Spectrum Disorder
    Matta, John
    Dobrino, Daniel
    Howard, Swade
    Yeboah, Dacosta
    Kopel, Jonathan
    El-Manzalawy, Yasser
    Obafemi-Ajayi, Tayo
    2021 43RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY (EMBC), 2021, : 2110 - 2114